UC San Francisco researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco.
David Raleigh, MD, PhD, is a radiation oncologist whose work focuses on understanding links between meningioma and the synthetic progesterone MPA that’s used in injectable birth control.
In September, our Office of Education and Training coordinated a Cancer Research Showcase for Graduate Students, designed to introduce the vibrant cancer research community at UCSF to students across PhD and MD/PhD programs who wish to pursue a degree in cancer biology.
Researchers from UC San Francisco, have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver.
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.
From curing Alzheimer’s to preventing cancer and pneumonia, UCSF postdoctoral scholars tackle complex medical conditions at annual Postdoc Slam competition.
Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.